Germany
Japan
United Kingdom
China
Antibodies
View as table Download
BLK Rabbit Polyclonal Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This BLK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BLK. |
Rabbit Polyclonal Antibody against BCL2L2
| Applications | IHC, WB |
| Reactivities | Human, Mouse (Predicted: Bovine) |
| Conjugation | Unconjugated |
| Immunogen | This Bcl antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 24-59 amino acids from human Bcl. |
Rabbit Polyclonal Antibody against PROX1 (Center)
| Applications | IHC, WB |
| Reactivities | Human (Predicted: Mouse) |
| Conjugation | Unconjugated |
| Immunogen | This PROX1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 185-214 amino acids from the Central region of human PROX1. |
Trpv3 (N-term) rabbit polyclonal antibody, Purified
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of mouse TRPV3. |
TGF beta Receptor I (TGFBR1) (Center) rabbit polyclonal antibody, Purified
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the central region of human TGFBR1. |
Active filters
Reactivities
- Mouse
Applications
- IHC
Isotypes
- Ig
Clonalities
- Polyclonal
Citations
- Yes
Filter by
Category
Target Symbol
Antibody Hosts
Conjugates
Families
Pathways
- Cell cycle (2)
- Progesterone-mediated oocyte maturation (2)
- Calcium signaling pathway (1)
- Chronic myeloid leukemia (1)
- Colorectal cancer (1)
- Cytokine-cytokine receptor interaction (1)
- Dilated cardiomyopathy (1)
- Gap junction (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- MAPK signaling pathway (1)
- Neuroactive ligand-receptor interaction (1)
- Oocyte meiosis (1)
- Other glycan degradation (1)
- Pancreatic cancer (1)
- Pathways in cancer (1)
- Purine metabolism (1)
- Renal cell carcinoma (1)
- Sphingolipid metabolism (1)
- TGF-beta signaling pathway (1)
- p53 signaling pathway (1)